Clinical Trials Browser

INDUSTRY × Recurrence × abexinostat × Clear all

NCT03934567 2025-04-10

A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma

Phase 2 Active not recruiting

Lymphoma, Follicular, Recurrence